Improving Single Donor Success Rate in Clinical Islet Transplantation Using Alpha-1 Antitrypsin (Aralast NP)
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 04 May 2017
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Transplant rejection; Type 1 diabetes mellitus
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 May 2017 Planned End Date changed from 1 Mar 2018 to 1 Mar 2020.
- 01 May 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Mar 2019.